Akademik Veri Yönetim Sistemi
INTERNATIONAL NEUROLOGICAL EMERGENCY SYMPOSIUM, 07 Aralık 2021
Background and Aim
SARS-CoV-2 binding ACE-2 receptors, so effected multi-system and organs. Brain is one of the most
affected organ. Encephalopathy is rare condition. In here we aimed presentation a case has
encephlopathy in COVID-19 infection.
Case
A 20-year girl admitted to the emergence clinic with complaints of conciousness, fever and vomiting
similar encephalitis. On physical examination, fever was 39 0 C, general condition poor. Cooperation
and orientation were not providing. Neck stifness was positive as meningeal irritation sign. Lomber
punction was made. In analysis of cerebro spinal fluid, there was not pathologic cell or leukocyte. All
biochemical arameters were normal. SARS-CoV-2 PCR test was positive. Ground glass opacity present
in high resolution torax tomography (HRCT). The patient was hospitalized in COVID-19 ward.
Mannitol and dexamethazone started as antiedema theatment. Additionally, COVID-19 supportive
therapy and favipiravir given to the patient. After one day cooperation provide to the patient. The
patients observed with supportive therapy 10 days. All symptoms and signs improved, and discharged
Conclusion
COVID-19 may present differen neurological involvement. Although encephalopathy is rara condition,
keep in mind in COVID-19 patients. Supportive therapy should be given.
1